Dose-dependent suppression of adrenocortical activity with metyrapone: Effects on emotion and memory

被引:145
作者
Roozendaal, B
Bohus, B
McGaugh, JL
机构
[1] UNIV CALIF IRVINE, DEPT PSYCHOBIOL, IRVINE, CA 92697 USA
[2] UNIV CALIF IRVINE, DEPT PHARMACOL, IRVINE, CA 92697 USA
[3] UNIV GRONINGEN, DEPT ANIM PHYSIOL, NL-9750 AA HAREN, NETHERLANDS
关键词
plasma corticosterone; glucocorticoid receptor; mineralocorticoid receptor; anxiety; fear; water maze; elevated plus-maze; immobility;
D O I
10.1016/S0306-4530(96)00028-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Different levels of circulating corticosterone are considered to produce different emotional states and effects on learning and memory. The purpose of the present study was to use different doses of the 11-beta-hydroxylase inhibitor metyrapone to produce dose-dependent inhibition of the synthesis of corticosterone and examine the consequences of that on several cognitive and emotional parameters. Systemic (SC) injections of metyrapone (25 or 50 mg/kg) dose-dependently suppressed increases in plasma concentrations of corticosterone induced by spatial training in a water maze, but did not affect plasma corticosterone levels in non-stressed rats. Treatment with the higher and lower dose of metyrapone also differentially affected behavioral measures of emotion and memory. Administration of 50 mg/kg, but not 25 mg/kg, of metyrapone impaired acquisition performance in the spatial water maze task. Both doses of metyrapone impaired retention. The impairment in retention was attenuated by dexamethasone (0.3 mg/kg) given systemically immediately after training, but not by corticosterone (0.3 mg/kg). During the exposure to a conditioned stressor of inescapable footshock, the higher, but not the lower dose of metyrapone attenuated fear induced immobility. In contrast, the lower, but not the higher dose attenuated the anxiety state in an elevated plus-maze in a novel environment immediately after exposure to the conditioned stressor. It is suggested that emotion, learning, and memory are differentially affected by the different doses of metyrapone due to interference with different types of adrenal steroid receptors and consequent induction of various corticosterone receptor states. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:681 / 693
页数:13
相关论文
共 35 条
[1]   MORPHOMETRICAL ANALYSIS OF THE DISTRIBUTION OF CORTICOTROPIN RELEASING-FACTOR, GLUCOCORTICOID RECEPTOR AND PHENYLETHANOLAMINE-N-METHYLTRANSFERASE IMMUNOREACTIVE STRUCTURES IN THE PARAVENTRICULAR HYPOTHALAMIC NUCLEUS OF THE RAT [J].
AGNATI, LF ;
FUXE, K ;
YU, ZY ;
HARFSTRAND, A ;
OKRET, S ;
WIKSTROM, AC ;
GOLDSTEIN, M ;
ZOLI, M ;
VALE, W ;
GUSTAFSSON, JA .
NEUROSCIENCE LETTERS, 1985, 54 (2-3) :147-152
[2]   THE NEURONAL MINERALOCORTICOID RECEPTOR AS A MEDIATOR OF GLUCOCORTICOID RESPONSE [J].
ARRIZA, JL ;
SIMERLY, RB ;
SWANSON, LW ;
EVANS, RM .
NEURON, 1988, 1 (09) :887-900
[3]   ROLE OF ENDOGENOUS CORTICOTROPIN-RELEASING FACTOR IN MEDIATION OF NEUROENDOCRINE AND BEHAVIORAL-RESPONSES TO CHOLECYSTOKININ OCTAPEPTIDE SULFATE ESTER IN RATS [J].
BIRO, E ;
SARNYAI, Z ;
PENKE, B ;
SZABO, G ;
TELEGDY, G .
NEUROENDOCRINOLOGY, 1993, 57 (02) :340-345
[4]   ADRENAL-STEROIDS AND EXTINCTION BEHAVIOR - ANTAGONISM BY PROGESTERONE, DEOXYCORTICOSTERONE AND DEXAMETHASONE OF A SPECIFIC EFFECT OF CORTICOSTERONE [J].
BOHUS, B ;
DEKLOET, ER .
LIFE SCIENCES, 1981, 28 (04) :433-440
[5]   BEHAVIORAL PHYSIOLOGY OF SEROTONERGIC AND STEROID-LIKE ANXIOLYTICS AS ANTISTRESS DRUGS [J].
BOHUS, B ;
KOOLHAAS, JM ;
KORTE, SM ;
BOUWS, GAH ;
EISENGA, W ;
SMIT, J .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1990, 14 (04) :529-534
[6]  
BOHUS B, 1994, ADV SERIES NEUROSCIE, V4, P337
[7]  
Bohus B., 1987, Neurobiological approaches to human disease, P267
[8]  
BOHUS B, 1982, CURRENT TOPICS NEURO, P107
[9]   CORTICOSTERONE DECREASES THE EFFICACY OF ADRENALINE TO AFFECT PASSIVE-AVOIDANCE RETENTION OF ADRENALECTOMIZED RATS [J].
BORRELL, J ;
DEKLOET, ER ;
BOHUS, B .
LIFE SCIENCES, 1984, 34 (01) :99-105
[10]   GLUCOCORTICOID AND MINERALOCORTICOID RECEPTOR MESSENGER-RNA EXPRESSION IN RAT-BRAIN [J].
CHAO, HM ;
CHOO, PH ;
MCEWEN, BS .
NEUROENDOCRINOLOGY, 1989, 50 (04) :365-371